| Rank | Logo | Name | Ticker | Market Cap | Price | Today % | Country |
|---|---|---|---|---|---|---|---|
| 1 |
|
Eli Lilly | LLY | $638.55 B | $712.31 | 0.97% | USA |
| 2 |
|
Johnson & Johnson | JNJ | $432.65 B | $179.65 | 0.45% | USA |
| 3 |
|
AbbVie | ABBV | $372.92 B | $211.10 | 0.93% | USA |
| 4 |
|
Roche | ROG.SW | $260.56 B | $325.18 | 0.04% | Switzerland |
| 5 |
|
AstraZeneca | AZN | $250.10 B | $80.66 | 0.18% | UK |
| 6 |
|
Novartis | NVS | $246.28 B | $127.22 | 0.02% | Switzerland |
| 7 |
|
Novo Nordisk | NVO | $245.45 B | $55.65 | 2.49% | Denmark |
| 8 |
|
Merck | MRK | $216.99 B | $86.88 | 2.62% | USA |
| 9 |
|
Thermo Fisher Scientific | TMO | $185.03 B | $490.01 | 0.97% | USA |
| 10 |
|
Amgen | AMGN | $159.79 B | $296.82 | 0.12% | USA |
| 11 |
|
Pfizer | PFE | $146.94 B | $25.84 | 1.83% | USA |
| 12 |
|
Gilead Sciences | GILD | $145.28 B | $117.09 | 1.38% | USA |
| 13 |
|
Sanofi | SNY | $123.87 B | $50.79 | 0.51% | France |
| 14 |
|
Vertex Pharmaceuticals | VRTX | $101.52 B | $395.99 | 0.41% | USA |
| 15 |
|
Bristol-Myers Squibb | BMY | $99.02 B | $48.65 | 0.81% | USA |
| 16 |
|
GlaxoSmithKline | GSK | $81.15 B | $40.27 | 0.51% | UK |
| 17 |
|
CSL | CSL.AX | $70.31 B | $145.21 | 2.38% | Australia |
| 18 |
|
Chugai Pharmaceutical | 4519.T | $70.09 B | $42.59 | 2.10% | Japan |
| 19 |
|
Zoetis | ZTS | $69.61 B | $157.08 | 0.20% | USA |
| 20 |
|
Regeneron Pharmaceuticals | REGN | $63.60 B | $600.14 | 1.54% | USA |
| 21 |
|
Alnylam Pharmaceuticals | ALNY | $61.08 B | $465.98 | 1.67% | USA |
| 22 |
|
Jiangsu Hengrui Medicine | 600276.SS | $59.50 B | $8.91 | 1.81% | China |
| 23 |
|
Samsung Biologics | 207940.KS | $51.69 B | $726.28 | 0.20% | S. Korea |
| 24 |
|
Lonza | LONN.SW | $49.26 B | $702.39 | 0.91% | Switzerland |
| 25 |
|
Takeda Pharmaceutical | TAK | $48.44 B | $15.34 | 0.90% | Japan |
| 26 |
|
Daiichi Sankyō | 4568.T | $46.72 B | $25.08 | 7.18% | Japan |
| 27 |
|
Sun Pharmaceutical | SUNPHARMA.NS | $45.10 B | $18.80 | 0.43% | India |
| 28 |
|
UCB | UCB.VI | $43.97 B | $231.43 | 2.18% | Belgium |
| 29 |
|
Argenx | ARGX | $40.53 B | $662.35 | 0.21% | Netherlands |
| 30 |
|
Galderma Group | GALD.SW | $39.70 B | $169.10 | 2.55% | Switzerland |
| 31 |
|
WuXi AppTec | 2359.HK | $38.17 B | $13.11 | 1.09% | China |
| 32 |
|
BeOne Medicines | ONC | $37.89 B | $311.74 | 0.78% | USA |
| 33 |
|
Agilent Technologies | A | $33.63 B | $118.42 | 0.58% | USA |
| 34 |
|
Bayer | BAYN.DE | $32.28 B | $32.71 | 0.63% | Germany |
| 35 |
|
DexCom | DXCM | $31.95 B | $81.49 | 0.22% | USA |
| 36 |
|
Otsuka Holdings | 4578.T | $28.58 B | $54.12 | 0.85% | Japan |
| 37 |
|
Novozymes | NZYM.VI | $28.27 B | $60.83 | 7.00% | Denmark |
| 38 |
|
Hansoh Pharma | 3692.HK | $27.88 B | $4.69 | 1.89% | China |
| 39 |
|
Celltrion | 068270.KS | $27.69 B | $122.33 | 0.41% | S. Korea |
| 40 |
|
Insmed | INSM | $27.65 B | $130.85 | 1.08% | USA |
| 41 |
|
BioNTech | BNTX | $26.51 B | $110.30 | 0.90% | Germany |
| 42 |
|
Sandoz Group | SDZ.SW | $26.26 B | $60.97 | 1.01% | Switzerland |
| 43 |
|
LabCorp | LH | $23.10 B | $278.10 | 0.00% | USA |
| 44 |
|
Innovent Biologics | 1801.HK | $21.72 B | $12.71 | 4.91% | China |
| 45 |
|
Royalty Pharma | RPRX | $21.33 B | $36.58 | 0.81% | UK |
| 46 |
|
Teva Pharmaceutical Industries | TEVA | $21.15 B | $18.42 | 4.57% | Israel |
| 47 |
|
Biogen | BIIB | $20.37 B | $139.00 | 0.01% | USA |
| 48 |
|
Astellas Pharma | 4503.T | $20.30 B | $11.34 | 1.12% | Japan |
| 49 |
|
Summit Therapeutics | SMMT | $19.35 B | $26.06 | 0.74% | UK |
| 50 |
|
Akeso | 9926.HK | $19.30 B | $21.50 | 3.32% | China |
| 51 |
|
Divis Laboratories | DIVISLAB.NS | $18.33 B | $69.08 | 0.38% | India |
| 52 |
|
Sichuan Biokin Pharmaceutical | 688506.SS | $18.15 B | $45.26 | 4.21% | China |
| 53 |
|
bioMérieux | BIM.PA | $17.46 B | $148.12 | 0.70% | France |
| 54 |
|
Incyte | INCY | $16.95 B | $86.82 | 0.71% | USA |
| 55 |
|
WuXi Biologics | WXXWY | $16.18 B | $8.00 | 2.56% | China |
| 56 |
|
Illumina | ILMN | $15.99 B | $101.03 | 0.23% | USA |
| 57 |
|
Alteogen | 196170.KQ | $15.43 B | $289.58 | 3.68% | S. Korea |
| 58 |
|
CSPC Pharmaceutical Group Limited | 1093.HK | $15.33 B | $1.34 | 1.35% | China |
| 59 |
|
Genmab | GMAB | $15.06 B | $24.48 | 1.75% | Denmark |
| 60 |
|
Shionogi | 4507.T | $14.94 B | $17.57 | 1.89% | Japan |
| 61 |
|
Cipla | CIPLA.NS | $14.74 B | $18.25 | 3.02% | India |
| 62 |
|
Torrent Pharmaceuticals | TORNTPHARM.NS | $14.14 B | $41.80 | 0.45% | India |
| 63 |
|
United Therapeutics | UTHR | $13.99 B | $309.48 | 0.98% | USA |
| 64 |
|
ICON plc | ICLR | $13.69 B | $176.05 | 2.33% | Ireland |
| 65 |
|
Tempus AI | TEM | $13.61 B | $78.36 | 6.93% | USA |
| 66 |
|
Neurocrine Biosciences | NBIX | $13.34 B | $134.60 | 1.03% | USA |
| 67 |
|
Medpace | MEDP | $12.88 B | $458.74 | 1.50% | USA |
| 68 |
|
Viatris | VTRS | $12.45 B | $10.68 | 0.33% | USA |
| 69 |
|
Baxter | BAX | $12.44 B | $24.22 | 0.19% | USA |
| 70 |
|
Recordati | REC.MI | $12.42 B | $60.57 | 0.67% | Italy |
| 71 |
|
Dr. Reddy's Laboratories | RDY | $12.13 B | $14.40 | 1.95% | India |
| 72 |
|
Mankind Pharma | MANKIND.NS | $11.93 B | $29.80 | 3.73% | India |
| 73 |
|
Ascendis Pharma | ASND | $11.81 B | $195.14 | 1.22% | Denmark |
| 74 |
|
Zydus Lifesciences | ZYDUSLIFE.NS | $11.36 B | $11.30 | 0.25% | India |
| 75 |
|
Orion Corporation | ORNAV.HE | $11.31 B | $79.99 | 0.43% | Finland |
| 76 |
|
Ipsen | IPN.PA | $11.18 B | $135.22 | 0.61% | France |
| 77 |
|
BioMarin Pharmaceutical | BMRN | $11.18 B | $58.24 | 0.48% | USA |
| 78 |
|
Huadong Medicine (HD Medicine) | 000963.SZ | $11.16 B | $6.37 | 0.20% | China |
| 79 |
|
Qiagen | QGEN | $10.70 B | $49.36 | 0.33% | Netherlands |
| 80 |
|
Revvity | RVTY | $10.54 B | $90.81 | 0.97% | USA |
| 81 |
|
Exelixis | EXEL | $10.38 B | $38.59 | 1.93% | USA |
| 82 |
|
Caris Life Sciences | CAI | $10.35 B | $36.83 | 5.01% | USA |
| 83 |
|
Lupin Limited | LUPIN.NS | $10.27 B | $22.49 | 1.14% | India |
| 84 |
|
Swedish Orphan Biovitrum | SOBI.ST | $10.25 B | $29.76 | 0.63% | Sweden |
| 85 |
|
Moderna | MRNA | $10.22 B | $26.27 | 2.31% | USA |
| 86 |
|
CSPC Innovation Pharmaceutical | 300765.SZ | $9.80 B | $6.98 | 2.10% | China |
| 87 |
|
Fosun Pharma | 600196.SS | $9.71 B | $3.89 | 0.50% | China |
| 88 |
|
BridgeBio Pharma | BBIO | $9.53 B | $49.86 | 2.00% | USA |
| 89 |
|
kyowa Kirin | 4151.T | $9.31 B | $17.78 | 0.74% | Japan |
| 90 |
|
Haisco Pharmaceutical Group | 002653.SZ | $9.17 B | $8.19 | 0.14% | China |
| 91 |
|
Verona Pharma | VRNA | $8.98 B | $105.72 | 0.07% | UK |
| 92 |
|
Madrigal Pharmaceuticals | MDGL | $8.96 B | $402.21 | 2.69% | USA |
| 93 |
|
Exact Sciences | EXAS | $8.88 B | $46.93 | 0.15% | USA |
| 94 |
|
Eisai | 4523.T | $8.84 B | $31.34 | 2.09% | Japan |
| 95 |
|
Elanco | ELAN | $8.73 B | $17.58 | 0.66% | USA |
| 96 |
|
Grifols | GRFS | $8.63 B | $10.09 | 0.59% | Spain |
| 97 |
|
Bio-Techne | TECH | $8.59 B | $54.84 | 0.95% | USA |
| 98 |
|
Halozyme Therapeutics | HALO | $8.43 B | $72.16 | 1.44% | USA |
| 99 |
|
Financière de Tubize | TUB.BR | $8.34 B | $187.42 | 1.77% | Belgium |
| 100 |
|
Roivant Sciences | ROIV | $7.98 B | $11.70 | 0.21% | UK |
Largest Biotech companies by market capitalization
*This list highlights the leading companies in this category, ranked by their market value. Only publicly traded companies are included, since private companies don’t share enough financial details to estimate their value.
Market capitalization (or market cap) is the total value of a public company. It’s usually calculated by multiplying the company’s share price by the number of shares available.
Stock prices may not always be live and can be delayed from a few minutes to several hours.
All company logos are owned by their respective copyright holders and are shown here for editorial use only.
